Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    "Porphyria cutanea tarda"
Show Display Options
Rank Status Study
1 Completed Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Intervention:
2 Completed
Has Results
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention: Drug: Deferasirox
3 Recruiting Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Interventions: Drug: Hydroxychloroquine;   Procedure: Phlebotomy
4 Unknown  Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention: Drug: Exjade
5 Completed Study of the Pathogenesis of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention:
6 Active, not recruiting EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Condition: Acute Hepatic Porphyria
Intervention:
7 Recruiting Oral Iron for Erythropoietic Protoporphyrias
Conditions: Erythropoietic Protoporphyria;   EPP;   X-linked Protoporphyria;   XLP
Intervention: Drug: Oral Iron
8 Recruiting Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Conditions: Erythropoietic Protoporphyria;   EPP;   X-Linked Protoporphyria;   XLP;   XLPP;   X-Linked Dominant Erythropoietic Protoporphyria;   XLEPP;   XLDP
Intervention:
9 Unknown  Phase III Confirmatory Study in Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
10 Withdrawn Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
Conditions: Erythropoietic Protoporphyria (EPP);   X Linked Erythropoietic Protoporphyria
Intervention: Drug: Isoniazid
11 Completed Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
12 Completed Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
13 Unknown  Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Interventions: Behavioral: exercise;   Behavioral: heat;   Procedure: red light illumination
14 Completed Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Intervention: Drug: cysteine hydrochloride
15 Completed Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Intervention: Drug: cysteine hydrochloride
16 Enrolling by invitation A Study to Evaluate Long-term Safety and Clinical Activity of ALN-AS1 in Patient With Acute Intermittent Porphyria (AIP)
Condition: Acute Intermittent Porphyria
Intervention: Drug: ALN-AS1
17 Active, not recruiting Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
Conditions: Anti-Psychotic;   Management of Manifestations of Psychotic Disorders;   Treatment of Schizophrenia;   Control Nausea and Vomiting;   Relief of Restlessness and Apprehension Before Surgery;   Acute Intermittent Porphyria;   Adjunct in the Treatment of Tetanus;   Control Manifestations of the Manic Type of Mani-depressive Illness;   Relief of Intractable Hiccups
Intervention: Drug: Chlorpromazine Hydrochloride
18 Enrolling by invitation Acute Porphyria Biomarkers
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Intervention: Drug: Hemin
19 Recruiting Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Interventions: Biological: Hemin for injection;   Other: Placebo
20 Recruiting A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)
Condition: Acute Intermittent Porphyria
Interventions: Drug: ALN-AS1;   Drug: Sterile Normal Saline (0.9% NaCl)

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.